Significance of ventricular late potentials in non-ischaemic dilated cardiomyopathy

D Denereaz1, M Zimmermann, R Adamec

  • 1Cardiology Center, University Hospital, Geneva, Switzerland.

Insights

Ventricular late potentials are common in non-ischaemic dilated cardiomyopathy, occurring in 43% of patients. Their presence is significantly associated with a history of sustained ventricular tachycardia, indicating clinical importance.

Area of Science:

  • Cardiology
  • Electrophysiology

Background:

  • Non-ischaemic dilated cardiomyopathy (DCM) is a significant cause of heart failure.
  • Ventricular late potentials (VLPs) are potential markers for arrhythmogenic substrates.
  • Assessing VLPs in DCM is crucial for risk stratification.

Purpose of the Study:

  • To determine the incidence of VLPs in patients with non-ischaemic DCM.
  • To evaluate the clinical significance of VLPs in relation to sustained ventricular tachycardia (VT).

Main Methods:

  • Signal-averaged electrocardiogram (SAECG) was performed on 51 DCM patients.
  • VLPs were defined by specific QRS duration and late potential interval criteria.
  • Patients were assessed for New York Heart Association (NYHA) class, ejection fraction, and history of VT.

Main Results:

  • VLPs were detected in 22 out of 51 patients (43%).
  • A history of sustained VT was present in 10 patients, with VLPs found in 80% of them.
  • VLPs were found in 34% of patients without a history of sustained VT (P < 0.01).

Conclusions:

  • Ventricular late potentials are prevalent in non-ischaemic dilated cardiomyopathy.
  • The presence of VLPs is significantly associated with a history of sustained ventricular tachycardia.
  • SAECG may aid in identifying DCM patients at higher risk for ventricular arrhythmias.

Related Concept Videos

Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
11.8K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753